US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find and treat patients with the mind-robbing disease that affects nearly 7 million Americans.
The test made by Fujirebio Diagnostics a unit of Japan’s H.U. Group Holdings was cleared for people 55 years and older who exhibit signs and symptoms of the disease, the US Food and Drug Administration said in a statement.
Loading…
Bloomberg